Published in Clinical Trials Week, June 4th, 2007
CytRx is planning to initiate in the first half of 2008 a Phase II clinical trial with its lead molecular chaperone-based drug candidate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.